These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3384618)

  • 1. Diatrizoate levels in cerebrospinal fluid following intravenous administration. Role of fluid production rate.
    Harnish PP; Northington FK; Samuel KA
    Invest Radiol; 1988 May; 23(5):377-80. PubMed ID: 3384618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced cerebrospinal fluid production in the rat and rabbit by diatrizoate. Ventriculocisternal perfusion.
    Harnish PP; Samuel K
    Invest Radiol; 1988 Jul; 23(7):534-6. PubMed ID: 3170143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic manipulation of the flushing action of cerebrospinal fluid. Effect on CSF diatrizoate levels.
    Harnish PP; Samuel K
    Invest Radiol; 1988 Dec; 23(12):914-7. PubMed ID: 2849595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased cerebrospinal fluid production by intravenous sodium diatrizoate.
    Harnish PP; DiStefano V
    Invest Radiol; 1984; 19(4):318-23. PubMed ID: 6434488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of vascular contrast media into brain tissue and cerebrospinal fluid. An experimental study in rats.
    Harnish PP; Mukherji M
    Invest Radiol; 1989 Jun; 24(6):463-6. PubMed ID: 2521128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological action of radiographic contrast media reduced cerebrospinal fluid production in the dog.
    Harnish PP; Distefano V
    J Pharmacol Exp Ther; 1985 Jan; 232(1):88-93. PubMed ID: 3155551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid transfer of contrast material at urography.
    McClennan BL; Becker JA
    Am J Roentgenol Radium Ther Nucl Med; 1971 Nov; 113(3):427-32. PubMed ID: 5127703
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of alteration of cerebrospinal fluid bulk flow on nicotine cerebrospinal fluid exit transfer kinetics.
    Karol MD; Veng-Pedersen P; Brashear RE; DeAtley RE
    J Pharm Sci; 1988 Jul; 77(7):571-8. PubMed ID: 3171944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of decreased cerebrospinal fluid production by radiographic contrast media: role of adenylate cyclase activation.
    Harnish PP; Northington FK; DiStefano V; Banerjee S
    J Pharmacol Exp Ther; 1986 Feb; 236(2):464-9. PubMed ID: 3003344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diatrizoate distribution in dogs as a function of administration rate and time following intravenous injection.
    Ono N; Martinez CR; Fara JW; Hodges FL
    J Comput Assist Tomogr; 1980 Apr; 4(2):174-7. PubMed ID: 7365015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intravenous and intracerebroventricular infusion of hypertonic solutions on plasma and cerebrospinal fluid vasopressin concentrations.
    Wang BC; Share L; Crofton JT; Kimura T
    Neuroendocrinology; 1982 Mar; 34(3):215-21. PubMed ID: 7070592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and cerebrospinal fluid concentrations of 4-aminopyridine following intravenous injection and metered intrathecal delivery in canines.
    Pratt K; Toombs JP; Widmer WR; Borgens RB
    J Neurotrauma; 1995 Feb; 12(1):23-39. PubMed ID: 7783231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intravenous sodium diatrizoate on the function of the transplanted canine kidney.
    DeWolf WC; Kim ES; Arora VK; Shafer RB; Miller J
    Invest Radiol; 1977; 12(1):81-4. PubMed ID: 320153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of high-performance liquid chromatography in the characterization of iatrogenic sodium diatrizoate-induced seizures in a horse.
    Fitzgerald SD; Braselton WE
    J Vet Diagn Invest; 2004 Sep; 16(5):473-5. PubMed ID: 15460337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisterna magna microdialysis of 22Na to evaluate ion transport and cerebrospinal fluid dynamics.
    Knuckey NW; Fowler AG; Johanson CE; Nashold JR; Epstein MH
    J Neurosurg; 1991 Jun; 74(6):965-71. PubMed ID: 2033458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bumetanide decreases canine cerebrospinal fluid production. In vivo evidence for NaCl cotransport in the central nervous system.
    Javaheri S; Wagner KR
    J Clin Invest; 1993 Nov; 92(5):2257-61. PubMed ID: 8227341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Production and absorption rate of cerebrospinal fluid in the spinal subarachnoid space of the dog (author's transl)].
    Watanabe K; Ishikawa S; Kimoto T; Nosaka K; Kajikawa H
    No Shinkei Geka; 1976 Apr; 4(4):351-8. PubMed ID: 944876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II decreases the rate of production of cerebrospinal fluid.
    Maktabi MA; Stachovic GC; Faraci FM
    Brain Res; 1993 Mar; 606(1):44-9. PubMed ID: 8462002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of the weakly protein-bound anionic compound diatrizoate in serum and synovial fluid of the horse.
    Frost AB; Larsen F; Larsen SW; Østergaard J; Thomsen MH; Stürup S; Andersen PH; Larsen C
    Pharm Res; 2010 Jan; 27(1):143-50. PubMed ID: 19876722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of halothane and fentanyl on the rate of CSF production in dogs.
    Artru AA
    Anesth Analg; 1983 Jun; 62(6):581-5. PubMed ID: 6846881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.